Brief: Baudax Bio Inc- On May 17, Received Delist Determination Letter From Nasdaq That Determined That Company Did Not Meet Terms Of Extension
19/05/2023 21:22
Baudax Bio Inc BXRX.O :
* BAUDAX BIO INC- ON MAY 17, RECEIVED DELIST DETERMINATION
LETTER
FROM NASDAQ THAT DETERMINED THAT COMPANY DID NOT MEET TERMS OF
EXTENSION
Source text for Eikon: ID:
Further company coverage: BXRX.O
Recent news on Baudax Bio
See all newsBrief: Baudax Bio On Feb 22, Filed Voluntary Petition Under Chapter 11 Of U.S. Bankruptcy Code
Brief: Baudax Bio Says Substantial Doubt Exists About Ability To Continue As A Going Concern For Next Twelve Months
Baudax Bio Inc expected to post a loss of 53 cents a share - Earnings Preview
Brief: Baudax Bio Says Phase 1/2a Clinical Study of TI-168 In Hemophilia A with FVIII Inhibitors Projected to Begin Q1 2024
Brief: Baudax Bio Inc - On October 5, 2023, Board Of Directors Of Company Appointed Natalie Mcandrew As Interim Chief Financial Officer